Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05986266Phase 1Completed
Phase 1, randomised trial of carbetocin in uterine fibroid (2 arms), sponsored by Egymedicalpedia. Primary endpoint: Intraoperative and Post operative bleeding at 2 hours. Started Feb 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05986266.